Viewing Study NCT02419560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-02-24 @ 2:08 PM
Study NCT ID: NCT02419560
Status: COMPLETED
Last Update Posted: 2022-05-24
First Post: 2015-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL
Sponsor: Craig Portell, MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Mantle-Cell View
None Recurrent Lymphoma, Mantle-Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed View
None Laboratory biomarker research View
None Pharmacologic study View
None Bruton's tyrosine kinase inhibitor View
None BCL-2 inhibitor View